Pericentromeric regions are refractory to prompt repair after replication stress-induced breakage in HPV16 E6E7-expressing epithelial cells

PLoS One. 2012;7(10):e48576. doi: 10.1371/journal.pone.0048576. Epub 2012 Oct 31.

Abstract

Chromosomal instability is the major form of genomic instability in cancer cells. Amongst various forms of chromosomal instability, pericentromeric or centromeric instability remains particularly poorly understood. In the present study, we found that pericentromeric instability, evidenced by dynamic formation of pericentromeric or centromeric rearrangements, breaks, deletions or iso-chromosomes, was a general phenomenon in human cells immortalized by expression of human papillomavirus type 16 E6 and E7 (HPV16 E6E7). In particular, for the first time, we surprisingly found a dramatic increase in the proportion of pericentromeric chromosomal aberrations relative to total aberrations in HPV16 E6E7-expressing cells 72 h after release from aphidicolin (APH)-induced replication stress, with pericentromeric chromosomal aberrations becoming the predominant type of structural aberrations (~70% of total aberrations). In contrast, pericentromeric aberrations accounted for only about 20% of total aberrations in cells at the end of APH treatment. This increase in relative proportion of pericentromeric aberrations after release from APH treatment revealed that pericentromeric breaks induced by replication stress are refractory to prompt repair in HPV16 E6E7-expressing epithelial cells. Telomerase-immortalized epithelial cells without HPV16 E6E7 expression did not exhibit such preferential pericentromeric instability after release from APH treatment. Cancer development is often associated with replication stress. Since HPV16 E6 and E7 inactivate p53 and Rb, and p53 and Rb pathway defects are common in cancer, our finding that pericentromeric regions are refractory to prompt repair after replication stress-induced breakage in HPV16 E6E7-expressing cells may shed light on mechanism of general pericentromeric instability in cancer.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aphidicolin / pharmacology
  • Blotting, Western
  • Cell Cycle / drug effects
  • Cell Line, Transformed
  • Centromere / genetics*
  • Chromosomal Instability / drug effects
  • Chromosomal Instability / genetics
  • Chromosome Aberrations / drug effects
  • Chromosome Breakage / drug effects
  • Cyclin-Dependent Kinase Inhibitor p16 / metabolism
  • DNA Repair*
  • DNA Replication / drug effects
  • DNA Replication / genetics
  • Epithelial Cells / drug effects
  • Epithelial Cells / metabolism*
  • Histones / metabolism
  • Humans
  • In Situ Hybridization, Fluorescence
  • Microscopy, Confocal
  • Oncogene Proteins, Viral / genetics*
  • Oncogene Proteins, Viral / metabolism
  • Papillomavirus E7 Proteins / genetics*
  • Papillomavirus E7 Proteins / metabolism
  • Repressor Proteins / genetics*
  • Repressor Proteins / metabolism
  • Spectral Karyotyping
  • Telomerase / genetics
  • Telomerase / metabolism

Substances

  • Cyclin-Dependent Kinase Inhibitor p16
  • E6 protein, Human papillomavirus type 16
  • H2AX protein, human
  • Histones
  • Oncogene Proteins, Viral
  • Papillomavirus E7 Proteins
  • Repressor Proteins
  • Aphidicolin
  • Telomerase

Grants and funding

This study was supported by a grant from The University of Hong Kong, Project No. 201007176014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.